News Medical1h
Scientists design strategy for preventing cardiotoxic effects of anthracyclines
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with international partners, has designed a strategy for preventing the cardiotoxic ...
Armed robbery in Revesby8h
Scientists Craft Heart-Safe Strategy for Cancer Drugs
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...
Scientists design an effective treatment strategy to prevent heart injury caused by a class of anticancer drugs
A team of scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC), working in collaboration with ...
Neurology Advisor14h
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
For people with diabetes, the use of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with a reduced risk for certain disorders and conditions.
Mineralys Therapeutics completes enrollment in Explore-CKD Phase 2 trial
Mineralys Therapeutics (MLYS) has completed enrollment in the Explore-CKD Phase 2 trial evaluating the efficacy and safety of lorundrostat for ...